Lapatinib

New Strategies for Breast Cancer Prevention Tied to Diabetes Drugs, Diet

June 08, 2017

Research by breast cancer expert Xiaohe Yang, M.D., Ph.D., shows that well-known drugs for type 2 diabetes and dietary factors may be the key to breast cancer prevention.    Kannapolis, N.C.– Research published in the last year by Xiaohe Yang, M.D., Ph.D., an associate professor at North Carolina Central University’s (NCCU) Nutrition Research Program at the North […]

Finding Strategies to Prevent Breast Cancer

March 02, 2017

Breast cancer expert Xiaohe Yang, MD, PhD, tackles this complex disease and the many factors involved in its treatment, prevention, and progression. Xiaohe Yang, MD, PhD, knows there is not a “one-size-fits-all” cure for breast cancer. He and his research team are instead identifying the factors involved in different breast cancer subtypes, testing novel preventative […]

Short-term early exposure to lapatinib confers lifelong protection from mammary tumor development in MMTV-erbB-2 transgenic mice

January 12, 2017

Zhikun Ma, Amanda B. Parris, Zhengzheng Xiao, Erin W. Howard, Stanley D. Kosanke, Xiaoshan Feng and Xiaohe Yang. Short-term early exposure to lapatinib confers lifelong protection from mammary tumor development in MMTV-erbB-2 transgenic mice. Journal of Experimental & Clinical Cancer Research (2017)36:6. Author Affiliations Julius L. Chambers Biomedical/Biotechnology Research Institute, Department of Biological and Biomedical […]

Cancerous inhibitor of PP2A is a novel molecular target and resistance factor of Lapatinib

April 22, 2015

Cancerous inhibitor of PP2A is a novel molecular target and resistance factor of Lapatinib, Journal of Cancer Research, April 22, 2015, Ming Zhao, Amanda Blackwelder, Harry Lee, and Xiaohe Yang Biomedical/Biotechnology Research Institute and Department of Biology, North Carolina Central University, Kannapolis, NC. Abstract 3557: Cancerous inhibitor of PP2A is a novel molecular target and resistance factor of Lapatinib Abstract […]